ClinicalTrials.Veeva

Menu

A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer

K

King Chulalongkorn Memorial Hospital

Status

Completed

Conditions

Esophageal Neoplasms

Treatments

Device: Olympus
Device: Cellvizio

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This descriptive cross sectional study aims to directly compare the diagnostic capability of the probed-based confocal laser endomicroscopy (pCLE) and the magnifying narrow band imaging (M-NBI) in the Lugol's voiding lesions.

Enrollment

44 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age over 20 years
  • Having histological-confirmed diagnosis of head and neck cancer
  • Having no esophageal symptoms

Exclusion criteria

  • Having index cancer of nasopharynx
  • History of esophageal surgery
  • Having esophageal stricture or obstruction
  • Having esophageal varices
  • Known case of esophageal cancer
  • Uncorrectable coagulopathy and thrombocytopenia
  • Pregnancy
  • Thyrotoxicosis
  • Creatinine clearance less than 30 ml/min
  • Allergy to iodine or fluorescein.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

44 participants in 1 patient group

Study
Experimental group
Description:
probe-based confocal laser endomicroscopy narrow band imaging with magnification
Treatment:
Device: Cellvizio
Device: Olympus

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems